A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
Launched by HOFFMANN-LA ROCHE · Oct 29, 2007
Trial Information
Current as of July 24, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Successful completion of Bonviva study BM16550 (NCT00048074), with at least 75% compliance
- • Ambulatory
- Exclusion Criteria:
- • Patients who completed the Bonviva study BM16550 (NCT00048074) \>3 months before the planned start date for this study
- • Malignant disease diagnosed since inclusion into previous study
- • Treatment with drugs affecting bone metabolism since inclusion into previous study
About Hoffmann La Roche
Hoffmann-La Roche, commonly known as Roche, is a global leader in biotechnology and pharmaceuticals, committed to advancing healthcare through innovative research and development. With a strong focus on oncology, immunology, infectious diseases, and central nervous system disorders, Roche leverages cutting-edge science to deliver transformative therapies and diagnostics. The company is dedicated to improving patient outcomes by conducting rigorous clinical trials and collaborating with healthcare professionals and organizations worldwide. Roche's unwavering commitment to precision medicine and personalized healthcare positions it at the forefront of the industry, driving progress in the quest for effective treatments and improved patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pretoria, , South Africa
Berlin, , Germany
Madison, Wisconsin, United States
Madrid, , Spain
Gainesville, Florida, United States
Omaha, Nebraska, United States
Liege, , Belgium
Aalborg, , Denmark
Ballerup, , Denmark
Vejle, , Denmark
Budapest, , Hungary
Siena, , Italy
Valeggio Sul Mincio, , Italy
Haugesund, , Norway
Oslo, , Norway
Stavanger, , Norway
Cape Town, , South Africa
St Louis, Missouri, United States
Fargo, North Dakota, United States
St. Leonards, , Australia
Sydney, , Australia
Bruxelles, , Belgium
Plzen, , Czech Republic
Praha, , Czech Republic
København, , Denmark
århus, , Denmark
Arenzano, , Italy
Mexico City, , Mexico
Monterrey, , Mexico
Grudziadz, , Poland
Krakow, , Poland
Sommerset West, , South Africa
Bismarck, North Dakota, United States
Lyon, , France
Orleans, , France
Omaha, Nebraska, United States
Hamburg, , Germany
Aberdeen, , United Kingdom
Essen, , Germany
Patients applied
Trial Officials
Clinical Trials
Study Director
Hoffmann-La Roche
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials